We Are Celerion
Our 40+ years of experience, innovative strategies, global capabilities, and expertise in early phase research make us faster than our competitors. That means you get key data sooner, enabling you to make earlier go/no-go decisions about your drug's development. It’s all in the name: Celerion is derived from the Latin celeritas (meaning swiftness and speed), which reflects our founding principle—that fast, reliable research is vital to a product's success.
Why Choose Celerion for Your Clinical Trial?
Our Capabilities as a Leading CRO
We’ve come a long way since our legacy company’s first clinical trial in 1969. Today, Celerion is one of the world's leading CROs in early phase research, working with pharmaceutical companies and patients around the globe. We are more than 1,000 full-time scientific and medical personnel with the skills to design, execute, and interpret complex clinical studies, while upholding the highest standard of ethics. Our facilities offer over 600 beds and are among the most extensive in the industry, and our clinical research professionals have extensive experience and expertise to help you transition through Proof of Concept and beyond across North America, Europe, and Asia. Using these resources, we help get your product into the world faster, so you can start making a difference in people’s lives.
When you work with Celerion, you get access to over 100 years of collective hands-on experience from our senior management team. Our CRO industry knowledge and expertise will help you surpass your competition.